Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

LifeTech Scientific Corporation (1302) Price & Analysis

1302 Stock Chart & Stats

HK$1.47-HK$0.08(-5.16%)
At close: 4:00 PM EDT
HKD 1.3HKD 1.4HKD 1.5HKD 1.63 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
HKD 1.45 - HKD 1.54
52-Week Range
HKD 1.26 - HKD 2.38
Previous Close
HKD 1.55
Volume
6.38M
Average Volume (3M)
21.76M
Market Cap
HKD 6.35B
Enterprise Value
HKD 4.58B
Total Cash (Recent Filing)
HKD 1.24B
Total Debt (Recent Filing)
HKD 14.10M
Price to Earnings (P/E)
98.2
Beta
0.66
Next Earnings
Mar 31, 2027
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

The sharp 2025 revenue re-acceleration indicates stronger demand and improving commercial traction across the company’s medical-device portfolio. If sustained, this growth can expand market presence, support operating investment, and provide a broader base for future earnings despite current profitability pressure.

Balance Sheet Strength

Extremely low leverage materially reduces financial risk and leaves the company less exposed to refinancing costs or balance-sheet stress. A conservative funding structure also preserves flexibility to invest in product development, commercialization, and expansion while absorbing periods of weaker profitability.

Free Cash Flow Quality

Free cash flow conversion near net income is a constructive indicator that reported earnings were supported by cash generation in 2025. This strengthens internal funding capacity for innovation and growth, reduces reliance on external capital, and supports resilience over the next several quarters.

Bears Say

Margin Compression

The sustained decline in net margin shows that strong revenue growth is not translating proportionally into earnings. Continued compression could limit operating leverage, reduce the cash available for reinvestment, and make future results more dependent on maintaining unusually high sales growth.

Weakening Capital Efficiency

Falling return on equity indicates that the expanding equity base is generating less profit than in earlier periods. Although this does not create balance-sheet risk, it signals weaker capital efficiency and may constrain long-term shareholder returns unless profitability improves or asset utilization becomes more productive.

Cash Conversion Volatility

The uneven relationship between operating profit and cash generation makes internally funded growth less predictable. Even with strong 2025 free cash flow conversion, recurring variability could complicate investment planning, reduce confidence in earnings quality, and create periods of lower financial flexibility.

LifeTech Scientific Corporation News

1302 FAQ

What was LifeTech Scientific Corporation’s price range in the past 12 months?
LifeTech Scientific Corporation lowest stock price was HK$1.26 and its highest was HK$2.38 in the past 12 months.
What is LifeTech Scientific Corporation’s market cap?
LifeTech Scientific Corporation’s market cap is HK$6.35B.
When is LifeTech Scientific Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were LifeTech Scientific Corporation’s earnings last quarter?
LifeTech Scientific Corporation released its earnings results on Aug 28, 2026. The company reported -HK$0.009 earnings per share for the quarter.
Is LifeTech Scientific Corporation overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does LifeTech Scientific Corporation pay dividends?
LifeTech Scientific Corporation does not currently pay dividends.
What is LifeTech Scientific Corporation’s EPS estimate?
LifeTech Scientific Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LifeTech Scientific Corporation have?
LifeTech Scientific Corporation has 4,631,712,400 shares outstanding.
What happened to LifeTech Scientific Corporation’s price movement after its last earnings report?
LifeTech Scientific Corporation reported an EPS of -HK$0.009 in its last earnings report. Following the earnings report the stock price went down -0.36%.
Which hedge fund is a major shareholder of LifeTech Scientific Corporation?
Currently, no hedge funds are holding shares in HK:1302
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology